Jan 6 () - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence ...
Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...
-- Collaboration leverages Variant Bio's innovative VB-Inference Platform and expertise partnering with global populations -- Commercial terms include an upfront payment and additional near-term R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback